Dialogue Health Technologies Inc.

TSX:CARE Stok Raporu

Piyasa değeri: CA$346.0m

Dialogue Health Technologies Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Dialogue Health Technologies has been growing earnings at an average annual rate of 7.2%, while the Healthcare industry saw earnings declining at 6.7% annually. Revenues have been growing at an average rate of 29.6% per year.

Anahtar bilgiler

7.2%

Kazanç büyüme oranı

22.9%

EPS büyüme oranı

Healthcare Sektör Büyümesi-6.7%
Gelir büyüme oranı29.6%
Özkaynak getirisi-21.5%
Net Marj-20.3%
Son Kazanç Güncellemesi30 Jun 2023

Yakın geçmiş performans güncellemeleri

Recent updates

Dialogue Health Technologies Inc.'s (TSE:CARE) Intrinsic Value Is Potentially 90% Above Its Share Price

Mar 14
Dialogue Health Technologies Inc.'s (TSE:CARE) Intrinsic Value Is Potentially 90% Above Its Share Price

Dialogue Health Technologies Inc. (TSE:CARE) Just Reported Earnings, And Analysts Cut Their Target Price

Nov 17
Dialogue Health Technologies Inc. (TSE:CARE) Just Reported Earnings, And Analysts Cut Their Target Price

An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 37% Undervalued

Jun 28
An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 37% Undervalued

An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 48% Undervalued

Feb 11
An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 48% Undervalued

Calculating The Fair Value Of Dialogue Health Technologies Inc. (TSE:CARE)

Nov 07
Calculating The Fair Value Of Dialogue Health Technologies Inc. (TSE:CARE)

Gelir ve Gider Dağılımı

Dialogue Health Technologies nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

TSX:CARE Gelir, gider ve kazançlar (CAD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 2396-206112
31 Mar 2392-205911
31 Dec 2287-255711
30 Sep 2280-234911
30 Jun 2274-234510
31 Mar 2269-234210
31 Dec 2165-248409
30 Sep 2163-251438
30 Jun 2153-251396
31 Mar 2147-247356
31 Dec 2036-21305
31 Dec 1910-12143
31 Dec 184-1083

Kaliteli Kazançlar: CARE is currently unprofitable.

Büyüyen Kar Marjı: CARE is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: CARE is unprofitable, but has reduced losses over the past 5 years at a rate of 7.2% per year.

Büyüme Hızlandırma: Unable to compare CARE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: CARE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-38.5%).


Özkaynak Getirisi

Yüksek ROE: CARE has a negative Return on Equity (-21.47%), as it is currently unprofitable.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin